Laurus Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

559.20

-13.35 (-2.33%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

559.20

-13.35 (-2.33%)
16:02 Dec 20

Quality

39/100
Medium Financial Strength

Valuation

16/100
Expensive Valuation

Technical

63/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	4813.51	4935.57	6040.55	5040.83	5053.2
Operating Expenses +	3262.83	3513.14	4448.36	4263.33	4280.76
Raw Material	2455.2	2414.94	2752.28	2533.3	2481.34
Increase Decrease in Cost	-297.01	-221.17	22.04	-100.88	-128.77
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	434.09	501.53	580.64	639.93	668.77
Miscellaneous Expenses	863.01	1109.46	1404.82	1412.82	1259.42
Operating Profit	1550.68	1422.43	1592.19	777.5	772.44
Other Income	23.66	13.58	6	26.34	28.07
Depreciation	205.07	251.49	324.08	384.58	414.23
Interest	68.16	100.67	165.17	182.9	203.12
Profit before tax and exceptio..	1301.11	1083.85	1108.94	236.36	183.16
Exceptional Items	0	0	0	0	0
PBT	1301.11	1083.85	1108.94	236.36	183.16
Provision for Taxation	317.29	251.42	312.3	68.15	52.74
Net Profit	983.82	832.43	796.64	168.21	130.42
NET Profit after MI	983.58	827.52	790.11	160.55	131.1
EPS	18.28	15.42	14.64	2.98	2.43
Operating Profit Margin (%)	32.22	28.82	26.36	15.42	15.29
Net Profit Margin (%)	20.43	16.77	13.08	3.19	2.59

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	27.20	27.20	27.20	27.20	27.20
FII	26.10	25.70	26.00	25.40	24.00
MF	8.20	9.20	6.70	5.60	5.30
Public	33.70	33.60	35.10	36.30	37.80
Others	0.00	0.00	0.00	0.00	0.00
Others	4.80	4.30	5.00	5.50	5.70